Ebola virus glycoproteins: guidance devices for targeting gene therapy vectors

Bibliography

• WALSH PD, ABERNETHY KA, BERMEJO M et al.: Catastrophic ape decline in western equatorial Africa. Nature (2003) 422:611–614.
   PubMed Web of Science ®Google Scholar
• BORIO L, INGLESBY T, PETERS CJ et al.: Hemorrhagic fever viruses as biological weapons: medical and public health management. JAMA (2002) 287:2391–2405.
   PubMed Web of Science ®Google Scholar
• OLSON KB: Aum Shinrikyo: once and future threat? Emerg. Infect. Dis. (1999) 5:513–516.
   Google Scholar
• SANDERS DA: No false start for novel pseudotyped vectors. Curt: Opin. Biotechnol. (2002) 13:437–442.
   PubMed Web of Science ®Google Scholar
• •A review of recent advances that includes a basic discussion of the principles of pseudotyping.
   Google Scholar
• TAKADA A, ROBISON C, GOTO H et al: A system for functional analysis of Ebola virus glycoprotein. Proc. Natl. Acad. Sci. USA (1997) 94:14764–14769.
   PubMed Web of Science ®Google Scholar
• DEPOLO NJ, REED JD, SHERIDAN PL et al.: VSV-G pseudotyped lentiviral vector particles produced in human cells are inactivated by human serum. Mol. Tiler. (2000) 2:218–222.
   PubMed Web of Science ®Google Scholar
• KANG Y, STEIN CS, HETH JA et al: ha vivo transfer using a nonprimate lentiviral vector pseudotyped with Ross River virus glycoproteins.Virol. (2002) 76:9378–9388.
   Web of Science ®Google Scholar
• VOLCHKOV VE, FELDMANN H, VOLCHKOVA VA, KLENK HD: Processing of the Ebola virus glycoprotein by the proprotein convertase furin. Proc. Natl. Acad. Sci. USA (1998) 95:5762–5767.
   PubMed Web of Science ®Google Scholar
• FELDMANN H, NICHOL ST, KLENK HD, PETERS CJ, SANCHEZ A: Characterization of filoviruses based on differences in structure and antigenicity of the virion glycoprotein. Virology (1994) 199:469–473.
   PubMed Web of Science ®Google Scholar
• SANCHEZ A, KILEY MP, HOLLOWAY BP, AUPERIN DD: Sequence analysis of the Ebola virus genome: organization, genetic elements, and comparison with the genome of Marburg virus. Virus Res. (1993) 29:215–240.
   PubMed Web of Science ®Google Scholar
• SANCHEZ A, YANG ZY, XU L et al: Biochemical analysis of the secreted and virion glycoproteins of Ebola virus. Vim/. (1998) 72:6442–6447.
   Web of Science ®Google Scholar
• JEFFERS SA, SANDERS DA, SANCHEZ A: Covalent modifications of the Ebola virus glycoprotein. Vim/. (2002) 76:12463–12472.
   Web of Science ®Google Scholar
• ••The study that demonstrates theadvantages of using the Ebola A309–489 GP for pseudotyping retroviruses. Also contains data on the evolutionary origins of the filovirus GPs.
   Google Scholar
• SANCHEZ A, TRAPPIER SG, MAHY BW, PETERS CJ, NICHOL ST: The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing. Proc. Natl. Acad. Sci. USA (1996) 93:3602–3607.
   PubMed Web of Science ®Google Scholar
• BUKREYEV A, VOLCHKOV VE, BLINOV VM, NETESOV SV: The GP-protein of Marburg virus contains the region similar to the 'immunosuppressive domain' of oncogenic retrovirus P15E proteins. FEBS Lett. (1993) 323:183–187.
   PubMed Web of Science ®Google Scholar
• VOLCHKOV VE, BLINOV VM, NETESOV SV: The envelope glycoprotein of Ebola virus contains an immunosuppressive-like domain similar to oncogenic retroviruses. FEBS Lett. (1992) 305:181–184.
   PubMed Web of Science ®Google Scholar
• PINTER A, KOPELMAN R, LIZ, KAYMAN SC, SANDERS DA: Localization of the labile disulfide bond between SU and TM of the murine leukemia virus envelope protein complex to a highly conserved CWLC motif in SU that resembles the active site sequence of thiol-disulfide exchange enzymes. Vim/. (1997) 71:8073–8077.
   Web of Science ®Google Scholar
• SANDERS DA: Sulfhydryl involvement in fusion mechanisms. In: Fusion of biological membranes and related problems Hilderson H, Fuller S (Eds), Kluwer Academic/Plenum Publishers (2000):483–514.
   Google Scholar
• FASS D, KIM PS: Dissection of a retrovirus envelope protein reveals structural similarity to influenza hemagglutinin. Carr. Biol. (1995) 5:1377–1383.
   PubMed Web of Science ®Google Scholar
• FASS D, HARRISON SC, KIM PS: Retrovirus envelope domain at 1.7 angstrom resolution. Nat. Struct. Biol. (1996) 3:465–469.
   PubMedGoogle Scholar
• MALASHKEVICH VN, SCHNEIDER BJ, MCNALLY ML et al.: Core structure of the envelope glycoprotein GP2 from Ebola virus at 1.9- A resolution. Proc. Nati Acad. Sci. USA (1999) 96:2662–2667.
   Google Scholar
• WEISSENHORN W, CARFI A, LEE KH, SKEHEL JJ, WILEY DC: Crystal structure of the Ebola virus membrane fusion subunit, GP2, from the envelope glycoprotein ectodomain. Mol. Cell (1998) 2:605–616.
   PubMed Web of Science ®Google Scholar
• KOBE B, CENTER RJ, KEMP BE, POUMBOURIOS P: Crystal structure of human T cell leukemia virus type 1 gp21 ectodomain crystallized as a maltose-binding protein chimera reveals structural evolution of retroviral transmembrane proteins. Proc. Natl. Acad. Sci. USA (1999) 96:4319–4324.
   PubMed Web of Science ®Google Scholar
• GALLAHER WR: Similar structural models of the transmembrane proteins of Ebola and avian sarcoma viruses. Cell (1996) 85:477–478.
   PubMed Web of Science ®Google Scholar
• WOOL-LEWIS RJ, BATES P: Characterization of Ebola virus entry by using pseudotyped viruses: identification of receptor-deficient cell lines. .I. Viral. (1998) 72:3155–3160.
   PubMed Web of Science ®Google Scholar
• •Investigation of the specificity of the entry of Ebola GP-pseudotyped retroviruses into cultured cells.
   Google Scholar
• MOTHES W, BOERGER AL, NARAYAN S, CUNNINGHAM JM, YOUNG JA: Retroviral entry mediated by receptor priming and low pH triggering of an envelope glycoprotein. Cell (2000) 103:679–689.
   PubMed Web of Science ®Google Scholar
• YANG Z, DELGADO R, XU L et al.:Distinct cellular interactions of secreted and transmembrane Ebola virus glycoproteins. Science (1998) 279:1034–1037.
   PubMed Web of Science ®Google Scholar
• •First description of Ebola GP-pseudotyped retroviruses.
   Google Scholar
• CHAN SY, SPECK RE MA MC, GOLDSMITH MA: Distinct mechanisms of entry by envelope glycoproteins of Marburg and Ebola (Zaire) viruses. J. Viral. (2000) 74:4933–4937.
   PubMed Web of Science ®Google Scholar
• SINN PL, HICKEY MA, STABER PD et al.: Lentivirus vectors pseudotyped with filoviral envelope glycoproteins transduce airway epithelia from the apical surface independently of folate receptor alpha. Virol. (2003) 77:5902–5910.
   Web of Science ®Google Scholar
• ••Three major conclusions: (1) the EbolaA309-489 GP has advantages for transduction by pseudotyped lentiviruses; (2) the pseudotyped viruses enter human airway epithelia from apical surface; (3) a previously identified factor is not essential for entry into airway epithelia.
   Google Scholar
• SUI J, MARASCO WA: Evidence against Ebola virus sGP binding to human neutrophils by a specific receptor. Virology (2002) 303:9–14.
   PubMed Web of Science ®Google Scholar
• MARUYAMA T, BUCHMEIER MJ, PARREN PWHI, BURTON DR: Ebola virus, neutrophils, and antibody specificity. Science (1998) 282:843.
   Google Scholar
• CHAN SY, EMPIG CJ, WELTE FJ et al: Folate receptor-alpha is a cofactor for cellular entry by Marburg and Ebola viruses. Cell (2001) 106:117–126.
   PubMed Web of Science ®Google Scholar
• •Identification of the folate receptor-a as a filovirus entry cofactor through use of pseudotyped viruses.
   Google Scholar
• SIMMONS G, REEVES JD, GROGAN CC et al.: DC-SIGN and DC-SIGNR bind ebola glycoproteins and enhance infection of macrophages and endothelial cells. Virology (2003) 305:115–123.
   PubMed Web of Science ®Google Scholar
• ALVAREZ CP, LASALA F, CARRILLO Jet al.: C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans. J. Vim/. (2002) 76:6841–6844.
   Google Scholar
• LIN G, SIMMONS G, POHLMANN S et al.: Differential N-linked glycosylation of human immunodeficiency virus and Ebola virus envelope glycoproteins modulates interactions with DC-SIGN and DC-SIGNR. Virol. (2003) 77:1337–1346.
   Web of Science ®Google Scholar
• WATSON DJ, KOBINGER GP, PASSINI MA, WILSON JM, WOLFE JH: Targeted transduction patterns in the mouse brain by lentivirus vectors pseudotyped with VSV, Ebola, Mokola, LCMV, Or. M I V envelope proteins. Ma The]: (2002) 5:528–537.
   Google Scholar
• JOHNSON E, JAAX N, WHITE J, JAHRLING P: Lethal experimental infections of rhesus monkeys by aerosolized Ebola virus. Int. J. Exp. Pathol (1995) 76:227–236.
   PubMed Web of Science ®Google Scholar
• RYABCHIKOVA E, STRELETS L, KOLESNIKOVA L, PYANKOV 0, SERGEEV A: Respiratory Marburg virus infection in guinea pigs. Arch. Vim]. (1996) 141:2177–2190.
   PubMed Web of Science ®Google Scholar
• KOBINGER GP, WEINER DJ, YU QC, WILSON JM: Filovirus-pseudotyped lentiviral vector can efficiently and stably transduce airway epithelia in vivo. Nat. Biotechnol (2001) 19:225–230.
   PubMed Web of Science ®Google Scholar
• ••Important first demonstration of thecapacity of Ebola GP-pseudotyped lentivirus to transduce airway epithelia.
   Google Scholar
• ANTONY AC: Folate receptors. Ann. Rev. Nuti: (1996) 16:501–521.
   PubMed Web of Science ®Google Scholar
• LISANTI MP, CARAS IW, DAVITZ MA, RODRIGUEZ-BOULAN E: A glycophospholipid membrane anchor acts as an apical targeting signal in polarized epithelial cells. J. Cell Biol. (1989) 109:2145–2156.
   PubMed Web of Science ®Google Scholar
• SANDRIN V, BOSON B, SALMON P et al.: Lentiviral vectors pseudotyped with a modified RD114 envelope glycoprotein show increased stability in sera and augmented transduction of primary lymphocytes and CD34+ cells derived from human and nonhuman primates. Blood (2002) 100:823–832.
   PubMed Web of Science ®Google Scholar
• MACKENZIE TC, KOBINGER GP, KOOTSTRA NA et al.: Efficient transduction of liver and muscle after M utero injection of lentiviral vectors with different pseudotypes. Mol. Ther. (2002) 6:349–358.
   PubMed Web of Science ®Google Scholar
• YANG ZY, DUCKERS HJ, SULLIVAN NJ et al.: Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury. Nat. Med. (2000) 6:886–889.
   PubMed Web of Science ®Google Scholar
• SIMMONS G, WOOL-LEWIS RJ, BARIBAUD F, NETTER RC, BATES P: Ebola virus glycoproteins induce global surface protein down-modulation and loss of cell adherence. J. Vim/. (2002) 76:2518–2528.
   Web of Science ®Google Scholar
• VOLCHKOV VE, VOLCHKOVA VA, MUHLBERGER E et al.: Recovery of infectious Ebola virus from complementary DNA: RNA editing of the GP gene and viral cytotoxicity. Science (2001) 291:1965–1969.
   PubMed Web of Science ®Google Scholar
• MEDINA MF, KOBINGER GP, RUX J et al.: Lentiviral vectors pseudotyped with minimal filovirus envelopes increased gene transfer in murine lung. MM. Ther. (2003) 8:777–789.
   PubMed Web of Science ®Google Scholar
• DRISKELL RA, ENGELHARDT JF: Current status of gene therapy for inherited lung diseases. Ann. Rev. Physic] (2003) 65:585–612.
   PubMed Web of Science ®Google Scholar
• WILSON JA, HEVEY M, BAKKEN R et al.: Epitopes involved in antibody-mediated protection from Ebola virus. Science (2000) 287:1664–1666.
   PubMed Web of Science ®Google Scholar
• BEARDSLEY T: Gene therapy setback. Sci. Am. (2000) 282:36–37.
   PubMed Web of Science ®Google Scholar
• RAPER SE, CHIRMULE N, LEE FS et al: Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. Ma Genet. Metab. (2003) 80:148–158.
   PubMed Web of Science ®Google Scholar